Perrigo | PRGO - Sales Revenues



Perrigo reported $1.06B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
AbbVie USD 15.42B 2.08B Jun/2025
Abbott USD 11.42B 1.06B Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
Corcept Therapeutics USD 194.4M 37.2M Jun/2025
Dr.Reddys Laboratories INR 85.45B 390M Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Merck USD 15.81B 280M Jun/2025
Nestle CHF 44.23B 2.08B Jun/2025
Pacira USD 181.1M 12.18M Jun/2025
Perrigo USD 1.06B 20M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Prestige Brands USD 249.53M 46.99M Jun/2025
Reckitt Benckiser GBP 3.3B 3.7B Jun/2025
Sanofi EUR 9.99B 90M Jun/2025
Supernus Pharmaceuticals USD 165.5M 15.7M Jun/2025
Teva Pharmaceutical Industries USD 14.06B 0 Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025
Zoetis USD 2.46B 240M Jun/2025